Scale Faster.

From small/large molecule to personalized medicine, leverage the power of Pharma 4.0 & increase your speed to market.

Learn More

AI in Drug Discovery and Manufacturing

Format: article

Topics: industry perspectives

Artificial intelligence is redefining the pharma and biotech industries, from drug development to patient care, enhancing the way we develop and manufacture drug treatments. Now more than ever, life science organizations are implementing intelligent technology systems to streamline those processes, improve efficiency and ultimately, increase speed to market.

The global AI in drug discovery market is growing rapidly as organizations address the challenges presented by COVID-19. The growing number of cross-industry collaborations / partnerships, rising costs and the demand for faster speed to market are key factors further influencing adoption.

Significant manufacturing costs also trickle down to patients around the world. Considering that almost half of the individuals in the U.S. have taken at least one prescription drug within the last 30 days, it’s key that organizations find ways to make drug manufacturing as efficient as possible.

What AI enabled systems can do:

Integrating artificial intelligence and machine learning approaches within the life science industry can help alleviate mounting pressure. The more insights you collect through intelligent systems, the faster your teams can work and accelerate critical project development.